Accumulating data support the systemic benefits of semaglutide (and potentially other GLP-1RA-based therapies) in people with obesity, meaning that cardiologists and other clinicians must become familiar with prescribing them particularly once market competition makes these drugs more accessible
You may be a good candidate if your BMI is 30 or higher, which is classified as obese
Normally, its After the FDA declared a semaglutide shortage in 2022, many compounding pharmacies and telehealth companies started offering compounded semaglutide to address the gap in availability
A qualitative study published in Nutrients found that restricting a time window felt less burdensome than counting calories, planning meals, or monitoring dietary intake for adults with type 2 diabetes
Can you lose weight after one year on semaglutide
Semaglutide is contraindicated in patients with type 1 diabetes